GLP-1 drugs , or glucagon-like peptide-1 analogs , represent a remarkable innovation in how we treat diabetes mellitus . These new drugs function to imitating the body’s own GLP-1 substance , which https://letusbookmark.com/story23726274/glp-1-a-revolutionary-approach-in-glucose-treatment